Fiche d'information compilée à partir de PubMed
Cette fiche a été compilée à partir de résumés PubMed (NIH) avec l'assistance d'une IA. Chaque affirmation factuelle est citée par un article PubMed réel (voir la liste des sources). Elle n'a pas encore été révisée par un humain — confirmez auprès d'un professionnel de santé avant utilisation.
Compilé à partir de 23 articles PubMed · modèle : gemma4:31b
Résumé
Contexte
Usages traditionnels
Composés actifs
Mécanisme d'action
Preuves cliniques
Covexir (F. foetida oleo-gum) significantly inhibited cough compared to placebo [PMID: 35896167]
Ethanolic extract of FFBR umbel significantly decreased ulcer area, showing efficacy superior to omeprazole [PMID: 34561804]
Hydroalcoholic extract of stems reduced systolic blood pressure and oxidative stress in dexamethasone-induced hypertensive rats [PMID: 26600859]
Extracts reversed gentamicin-induced nephrotoxicity, reducing blood urea nitrogen and serum creatinine [PMID: 27847458]
Ferulic acid decreased cell viability and suppressed metastatic potential in MDA-MB-231 cells [PMID: 27177074]
Root extracts showed antimicrobial activity, particularly against Gram-positive bacteria [PMID: 25430396]
Synthèse des preuves
Sources PubMed
- 1.PMID: 12444696 (2002) — Polysulfide derivatives from Ferula foetida. · Journal of natural products
- 2.PMID: 33155997 (2021) — Possible role of Unani Pharmacology in COVID-19 - a narrative review. · Reviews on environmental health
- 3.PMID: 37361940 (2023) — Efficacy and Safety of Add-On Plant-Based Drugs for COVID-19 Patients: A Review of the Randomized Control Trials. · Infection and drug resistance
- 4.PMID: 34561804 (2022) — Therapeutic potential of Ferula foetida(Bunge) Regel on gastric ulcer model in rats. · Environmental science and pollution research international
- 5.PMID: 35896167 (2022) — Efficacy of Covexir® (Ferula foetida oleo-gum) treatment in symptomatic improvement of patients with mild to moderate COVID-19: A randomized, double-blind, placebo-controlled trial.